Allakos Inc. (ALLK) Reaches $37.61 Formed H&S; Gcp Applied Technologies (GCP) Shorts Decreased By 3.44%

GCP Applied Technologies Inc. (NYSE:GCP) Logo

Gcp Applied Technologies Inc (NYSE:GCP) had a decrease of 3.44% in short interest. GCP’s SI was 3.91M shares in April as released by FINRA. Its down 3.44% from 4.05M shares previously. With 375,900 avg volume, 10 days are for Gcp Applied Technologies Inc (NYSE:GCP)’s short sellers to cover GCP’s short positions. The SI to Gcp Applied Technologies Inc’s float is 6.42%. The stock decreased 1.60% or $0.46 during the last trading session, reaching $28.25. About 257,194 shares traded. GCP Applied Technologies Inc. (NYSE:GCP) has declined 5.67% since April 23, 2018 and is downtrending. It has underperformed by 10.04% the S&P500. Some Historical GCP News: 22/03/2018 - GCP STUDENT LIVING PLC DIGS.L - HY DIVIDENDS FOR PERIOD 2.82P; 27/03/2018 - GCP Infrastructure Investments Arranges GBP150 Mln Credit Facility; 09/05/2018 - GAMCO BOOSTED DPS, HAWK, DWDP, GCP, TXT IN 1Q: 13F; 08/05/2018 - GCP APPLIED 1Q ADJ EPS 1C, EST. 3C; 08/05/2018 - GCP Applied Technologies Raises 2018 View To Adj EPS 99c-Adj EPS $1.18; 30/04/2018 - 3DR Launches GCP App; 14/05/2018 - CRN Exclusive: Google Adds New Life Science Platform Partners To GCP; 14/05/2018 - Verifi Issues Eye-Opening Report lllustrating the Damaging Effects of Chargebacks; 26/03/2018 - GCP Applied Technologies To Amend Its Existing Revolving Credit Facility to Increase the Revolving Commitments Thereunder to Up to $350M; 25/05/2018 - CTI BIOPHARMA - EMA’S FEB 2018 FINAL GCP INSPECTION REPORT CONCLUDED PERSIST-2 CLINICAL TRIAL OF PACRITINIB GENERALLY CONDUCTED IN COMPLIANCE WITH GCP

Allakos Inc. (ALLK) formed H&S with $34.60 target or 8.00% below today’s $37.61 share price. Allakos Inc. (ALLK) has $1.62B valuation. The stock decreased 0.11% or $0.04 during the last trading session, reaching $37.61. About 99,540 shares traded. Allakos Inc. (NASDAQ:ALLK) has 0.00% since April 23, 2018 and is . It has underperformed by 4.37% the S&P500.

More notable recent GCP Applied Technologies Inc. (NYSE:GCP) news were published by: Seekingalpha.com which released: “Google Embraces Multi-Cloud Strategy With Anthos - Seeking Alpha” on April 10, 2019, also Globenewswire.com with their article: “GCP Board of Directors Issues Open Letter to Shareholders - GlobeNewswire” published on February 27, 2019, Globenewswire.com published: “GCP Applied Technologies Inc. Announces Agreement with Starboard - GlobeNewswire” on March 11, 2019. More interesting news about GCP Applied Technologies Inc. (NYSE:GCP) were released by: Globenewswire.com and their article: “GCP Applied Technologies Reports Third Quarter 2018 Results - GlobeNewswire” published on November 06, 2018 as well as Globenewswire.com‘s news article titled: “GCP Applied Technologies Inc. Names James E. Thompson Vice President, General Counsel and Secretary - GlobeNewswire” with publication date: March 19, 2019.

GCP Applied Technologies Inc. produces and sells specialty construction chemicals, specialty building materials, and packaging sealants and coatings worldwide. The company has market cap of $2.05 billion. The Company’s Specialty Construction Chemicals segment offers concrete admixtures under the ADVA, STRUX, MIRA, POLARSET, ECLIPSE, DARACEM, DARASET, DCI, RECOVER, WRDA, and ZYLA brands; admixtures for decorative concrete under the PIERI brand; concrete production management system under the VERIFI brand; and cement additives under the CBA, SYNCHRO, HEA2, TDA, and ESE brands. It has a 133.89 P/E ratio. The companyÂ’s Specialty Building Materials segment provides building envelope products to protect structures from water, and manages air and vapor transmission through building walls under the BITUTHENE, PREPRUFE, ADPRUFE, HYDRODUCT, ADCOR, SILCOR, and PERM-A-BARRIER brands; and residential building products comprising roofing underlayments, flashings, and weather barriers under the ICE & WATER SHIELD, TRI-FLEX, and VYCOR brands.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.